| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ioanna Tzoulaki | Q63378793 |
| Maria Timofeeva | Q64609845 | ||
| Evropi Theodoratou | Q30438198 | ||
| P2093 | author name string | Xue Li | |
| Harry Campbell | |||
| Konstantinos K Tsilidis | |||
| Xiangrui Meng | |||
| P A Ioannidis | |||
| P2860 | cites work | Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease | Q21091170 |
| Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials | Q22306552 | ||
| Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathy | Q24202191 | ||
| Excess Significance Bias in the Literature on Brain Volume Abnormalities | Q24273222 | ||
| An exploratory test for an excess of significant findings | Q24273224 | ||
| Selection in reported epidemiological risks: an empirical assessment | Q24288769 | ||
| 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia | Q24612292 | ||
| Genome-wide association analyses identify 18 new loci associated with serum urate concentrations | Q24620065 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis | Q24805426 | ||
| Serum Uric Acid Increases Risk of Cancer Incidence and Mortality: A Systematic Review and Meta-Analysis | Q26778698 | ||
| Uric acid as a predictor of in-hospital mortality in acute myocardial infarction: a meta-analysis | Q38228496 | ||
| Serum Uric Acid Levels and Diabetic Peripheral Neuropathy in Type 2 Diabetes: a Systematic Review and Meta-analysis | Q38314588 | ||
| Serum Uric Acid Levels and Outcomes After Acute Ischemic Stroke | Q38368304 | ||
| Serum uric acid levels and risk of prehypertension: a meta-analysis | Q38379314 | ||
| High serum uric acid and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis | Q38383877 | ||
| Inverse Association Between Serum Uric Acid Levels and Alzheimer's Disease Risk | Q38530412 | ||
| Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis | Q38583375 | ||
| Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses | Q38688811 | ||
| Hyperuricemia and the Prognosis of Hypertensive Patients: A Systematic Review and Meta-Analysis | Q38849699 | ||
| Uric acid levels in subjects with bipolar disorder: A comparative meta-analysis. | Q38904411 | ||
| Urate-lowering therapy for asymptomatic hyperuricaemia: A need for caution | Q38945634 | ||
| The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses | Q38952676 | ||
| Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population | Q39382635 | ||
| Association of four genetic loci with uric acid levels and reduced renal function: the J-SHIPP Suita study | Q39846992 | ||
| Association Between Serum Uric Acid Levels and Atrial Fibrillation Risk | Q39847949 | ||
| Exposure-wide epidemiology: revisiting Bradford Hill | Q40233002 | ||
| No causal effect of serum urate on bone-related outcomes among a population of postmenopausal women and elderly men of Chinese Han ethnicity--a Mendelian randomization study | Q40296281 | ||
| A causal relationship between uric acid and diabetic macrovascular disease in Chinese type 2 diabetes patients: A Mendelian randomization analysis. | Q40807571 | ||
| A Mendelian Randomization Study of Circulating Uric Acid and Type 2 Diabetes. | Q41006854 | ||
| Mendelian randomization analysis to examine for a causal effect of urate on bone mineral density | Q41696507 | ||
| A re-evaluation of random-effects meta-analysis. | Q41866179 | ||
| Variation in the uric acid transporter gene (SLC2A9) and memory performance | Q43144722 | ||
| Plasma uric acid and hypertension in a Chinese community: prospective study and metaanalysis | Q43514352 | ||
| Risk factors for cardiovascular disease: one down, many more to evaluate | Q43580794 | ||
| Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study | Q43917180 | ||
| Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study | Q44086403 | ||
| Serum uric acid and risk of dementia in Parkinson's disease | Q44248135 | ||
| Predictors of stroke mortality in elderly people from the general population. The CArdiovascular STudy in the ELderly | Q44280158 | ||
| Serum uric acid levels and incidence of impaired fasting glucose and type 2 diabetes mellitus: A meta-analysis of cohort studies | Q44955019 | ||
| Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function | Q45256069 | ||
| Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified | Q45671624 | ||
| Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). | Q45948035 | ||
| Genetic variability related to serum uric acid concentration and risk of Parkinson's disease. | Q45980386 | ||
| Nature Versus Nurture in Gout: A Twin Study | Q50961728 | ||
| Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality | Q51352316 | ||
| Decreased plasma antioxidants in patients with Alzheimer's disease | Q51920410 | ||
| The correlation between uric acid and the incidence and prognosis of kidney diseases: a systematic review and meta-analysis of cohort studies | Q53090686 | ||
| Influence of serum uric acid levels on prognosis and survival in amyotrophic lateral sclerosis: a meta-analysis | Q57176144 | ||
| No evidence for a causal link between uric acid and type 2 diabetes: a Mendelian randomisation approach | Q57202652 | ||
| Variation in the Uric Acid Transporter Gene SLC2A9 and Its Association with AAO of Parkinson’s Disease | Q57273759 | ||
| Association of Uric Acid Genetic Risk Score With Blood Pressure | Q57366493 | ||
| Associations between serum uric acid and markers of subclinical atherosclerosis in young adults. The cardiovascular risk in Young Finns study | Q57417382 | ||
| Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study | Q57740599 | ||
| Uric acid and cardiovascular risk | Q79689991 | ||
| Serum urate and the risk of Parkinson's disease: results from a meta-analysis | Q85723240 | ||
| A genetic marker of uric acid level, carotid atherosclerosis, and arterial stiffness: a family-based study | Q85736032 | ||
| Association between hyperuricemia and clinical adverse outcomes after percutaneous coronary intervention: A meta-analysis | Q86122020 | ||
| Association between serum uric acid and atrial fibrillation recurrence following catheter ablation: A meta-analysis | Q86887249 | ||
| Hyperuricemia is independently associated with increased risk of atrial fibrillation: A meta-analysis of cohort studies | Q86939556 | ||
| Serum uric acid as a predictor for cardiovascular and all-cause mortality in women versus men | Q86960562 | ||
| A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study | Q87829165 | ||
| Calculating statistical power in Mendelian randomization studies. | Q37253510 | ||
| Hyperuricemia and risk of stroke: a systematic review and meta-analysis | Q37271211 | ||
| Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study | Q37306126 | ||
| Association between serum uric acid and development of type 2 diabetes. | Q37319097 | ||
| Low uric acid levels in patients with Parkinson's disease: evidence from meta-analysis | Q37342416 | ||
| AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions--agency for healthcare research and quality and the effective health-care program | Q37549075 | ||
| Gout, hyperuricemia, and Parkinson's disease: a protective effect? | Q37738123 | ||
| Uric acid and the development of hypertension | Q37795545 | ||
| Is there anything good in uric acid? | Q37930298 | ||
| Serum uric acid levels in patients with multiple sclerosis: a meta-analysis | Q37983970 | ||
| Uric acid and the origins of hypertension | Q38081007 | ||
| Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis | Q38122527 | ||
| Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis | Q38138322 | ||
| Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies | Q38152501 | ||
| Hyperuricemia and risk of stroke: a systematic review and meta-analysis of prospective studies | Q38182215 | ||
| Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis | Q38202745 | ||
| Uric acid and risk of heart failure: a systematic review and meta‐analysis | Q26852555 | ||
| The roles of biomarkers of oxidative stress and antioxidant in Alzheimer's disease: a systematic review | Q27008396 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| Common variants related to serum uric acid concentrations are associated with glucose metabolism and insulin secretion in a Chinese population | Q28543082 | ||
| Serum uric acid and adiposity: deciphering causality using a bidirectional Mendelian randomization approach | Q28728265 | ||
| Serum uric acid and mortality in chronic kidney disease: A systematic review and meta-analysis | Q30248550 | ||
| 2016 updated EULAR evidence-based recommendations for the management of gout | Q30248787 | ||
| Effect of Allopurinol on Blood Pressure: A Systematic Review and Meta‐Analysis | Q31118679 | ||
| Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? | Q33221221 | ||
| Accuracy of serum uric acid determination in predicting pre-eclampsia: a systematic review | Q33245845 | ||
| The GRADE system for rating clinical guidelines | Q33503214 | ||
| Meta-Analysis of Oxidative Stress in Schizophrenia | Q33601360 | ||
| Hyperuricemia and incident hypertension: a systematic review and meta-analysis. | Q33687506 | ||
| Association of a polymorphism in a gene encoding a urate transporter with CKD progression | Q33715840 | ||
| Replication of the effect of SLC2A9 genetic variation on serum uric acid levels in American Indians | Q33765218 | ||
| Uric acid as one of the important factors in multifactorial disorders – facts and controversies | Q33773142 | ||
| Serum uric acid is associated with incident chronic kidney disease in middle-aged populations: a meta-analysis of 15 cohort studies | Q33800813 | ||
| Bayesian methods for instrumental variable analysis with genetic instruments ('Mendelian randomization'): example with urate transporter SLC2A9 as an instrumental variable for effect of urate levels on metabolic syndrome | Q33884926 | ||
| Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study | Q33887961 | ||
| Uric acid: a novel mediator and marker of risk in chronic kidney disease? | Q33913892 | ||
| Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies | Q34042891 | ||
| A simple method for converting an odds ratio to effect size for use in meta-analysis | Q34103097 | ||
| Effects of Hyperuricemia on Renal Function of Renal Transplant Recipients: A Systematic Review and Meta-Analysis of Cohort Studies | Q34321410 | ||
| Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline | Q34336412 | ||
| A causal role for uric acid in fructose-induced metabolic syndrome | Q34460827 | ||
| Effects of Urate-Lowering Therapy in Hyperuricemia on Slowing the Progression of Renal Function: A Meta-Analysis | Q34468472 | ||
| Mendelian randomization of serum urate and parkinson disease progression | Q34576895 | ||
| Uric acid and oxidative stress: relative impact on cardiovascular risk? | Q34581253 | ||
| High Serum Uric Acid and Increased Risk of Type 2 Diabetes: A Systemic Review and Meta-Analysis of Prospective Cohort Studies | Q34599618 | ||
| Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies | Q34601785 | ||
| Mendelian randomization provides no evidence for a causal role of serum urate in increasing serum triglyceride levels | Q34734573 | ||
| Urate as a physiological substrate for myeloperoxidase: implications for hyperuricemia and inflammation | Q34787028 | ||
| The role of uric acid in stroke: the issue remains unresolved. | Q34794610 | ||
| Associations of serum uric acid and SLC2A9 variant with depressive and anxiety disorders: a population-based study | Q35034635 | ||
| Hyperuricemia as an independent predictor of vascular complications and mortality in type 2 diabetes patients: a meta-analysis | Q35036205 | ||
| Associations of the uric acid related genetic variants in SLC2A9 and ABCG2 loci with coronary heart disease risk | Q35041324 | ||
| Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants | Q35137931 | ||
| Serum uric acid levels in patients with Alzheimer's disease: a meta-analysis | Q35143061 | ||
| Effects of allopurinol on endothelial dysfunction: a meta-analysis | Q35153967 | ||
| Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. | Q35166411 | ||
| Effect of uric-acid-lowering therapy on progression of chronic kidney disease: a meta-analysis | Q35227649 | ||
| Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways | Q35230437 | ||
| Plasma Urate and Risk of a Hospital Stay with AKI: The Atherosclerosis Risk in Communities Study | Q35576084 | ||
| Xanthine oxidase inhibitors in heart failure: where do we go from here? | Q35627837 | ||
| Blood-borne biomarkers of mortality risk: systematic review of cohort studies | Q35651148 | ||
| On-admission serum uric acid predicts outcomes after acute myocardial infarction: systematic review and meta-analysis of prognostic studies | Q35929324 | ||
| Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors | Q36020848 | ||
| Low serum uric acid levels in patients with multiple sclerosis and neuromyelitis optica: An updated meta-analysis | Q36137434 | ||
| Birth weight in relation to health and disease in later life: an umbrella review of systematic reviews and meta-analyses | Q36146180 | ||
| Observations on Certain Pathological Conditions of the Blood and Urine in Gout, Rheumatism and Bright's Disease | Q36182898 | ||
| Uric Acid and Cardiovascular Events: A Mendelian Randomization Study | Q36223277 | ||
| Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease | Q36441852 | ||
| Genomics and metabolomics of muscular mass in a community-based sample of UK females | Q36475044 | ||
| Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis | Q36506786 | ||
| Plasma urate and risk of Parkinson's disease | Q36667290 | ||
| Short communication: genetic variations of SLC2A9 in relation to Parkinson's disease | Q36686805 | ||
| Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis | Q36724236 | ||
| Genotype-based changes in serum uric acid affect blood pressure | Q36808243 | ||
| Serum urate and the risk of major coronary heart disease events | Q36846981 | ||
| Association of Serum Uric Acid Levels in Psoriasis: A Systematic Review and Meta-Analysis | Q36993602 | ||
| Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts | Q37023991 | ||
| Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? | Q37078795 | ||
| Hyperuricaemia--where nephrology meets rheumatology | Q37149663 | ||
| Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress | Q37167578 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | uric acid | Q105522 |
| gout | Q133087 | ||
| heterocyclic compound | Q193430 | ||
| nephrolithiasis | Q18557037 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | j2376 | |
| P577 | publication date | 2017-06-07 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies | |
| P478 | volume | 357 |
| Q62737084 | An atlas of polygenic risk score associations to highlight putative causal relationships across the human phenome |
| Q90247760 | Assessment Causality in Associations Between Serum Uric Acid and Risk of Schizophrenia: A Two-Sample Bidirectional Mendelian Randomization Study |
| Q90435436 | Association of Antidepressant Use With Adverse Health Outcomes: A Systematic Umbrella Review |
| Q61811517 | Circulating antioxidants and Alzheimer disease prevention: a Mendelian randomization study |
| Q58557291 | Conjugation of urate-derived electrophiles to proteins during normal metabolism and inflammation |
| Q55476982 | Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD). |
| Q92848480 | Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements |
| Q59796190 | Dissociation between urate and blood pressure in mice and in people with early Parkinson's disease |
| Q48227892 | Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and its kidney clearance: post-hoc analyses of four clinical trials |
| Q91559056 | Fine mapping and identification of serum urate loci in American Indians: The Strong Heart Family Study |
| Q49498180 | Fructose metabolism and metabolic disease |
| Q64120001 | Gene-environment interactions and colorectal cancer risk: An umbrella review of systematic reviews and meta-analyses of observational studies |
| Q92785661 | Genetically Determined Uric Acid and the Risk of Cardiovascular and Neurovascular Diseases: A Mendelian Randomization Study of Outcomes Investigated in Randomized Trials |
| Q99728727 | Global assessment of C-reactive protein and health-related outcomes: an umbrella review of evidence from observational studies and Mendelian randomization studies |
| Q90317380 | Gout |
| Q92547767 | Human Immunodeficiency Virus Infection and Diverse Physical Health Outcomes: An Umbrella Review of Meta-analyses of Observational Studies |
| Q57285556 | Hyperferritinaemia and hyperuricaemia - a causal connection? |
| Q61442976 | Hyperuricemia Predicts an Early Decline in Renal Function among Older People: A Community-Based Cohort Study |
| Q92816159 | Hyperuricemia is associated with intermittent hand joint pain in a cross sectional study of elderly females: The AGES-Reykjavik Study |
| Q93145415 | Integration of Pharmacometrics and Pharmacoeconomics to Quantify the Value of Improved Forgiveness to Nonadherence: A Case Study of Novel Xanthine Oxidase Inhibitors for Gout |
| Q90469104 | Low-value injury care in the adult orthopaedic trauma population: a protocol for a rapid review |
| Q50044432 | MR-PheWAS: exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank. |
| Q63684307 | Magnesium and health outcomes: an umbrella review of systematic reviews and meta-analyses of observational and intervention studies |
| Q90615480 | Mild Hyperuricemia: To Treat, or Not to Treat, That is the Question. Suggestions form the URRAH Study |
| Q92227108 | Mouse models for human hyperuricaemia: a critical review |
| Q64123458 | Perspective: Limiting Dependence on Nonrandomized Studies and Improving Randomized Trials in Human Nutrition Research: Why and How |
| Q55163806 | Physiology of Hyperuricemia and Urate-Lowering Treatments. |
| Q56391583 | Prevalence and outcomes of incidental imaging findings: umbrella review |
| Q91967645 | Repeated measurements of serum urate and mortality: a prospective cohort study of 152,358 individuals over 8 years of follow-up |
| Q91942549 | Serum Uric Acid Level and Multiple Sclerosis: A Mendelian Randomization Study |
| Q93186480 | Serum Uric Acid Status and Its Association with Bone Mineral Density in the Elderly People Aged 60 Years and More |
| Q89387516 | Serum uric acid and arterial hypertension-Data from Sephar III survey |
| Q92740831 | Serum uric acid levels and cardiovascular mortality in a general Japanese population: the Hisayama Study |
| Q94554112 | Sex- and age-specific variations, temporal trends and metabolic determinants of serum uric acid concentrations in a large population-based Austrian cohort |
| Q90442174 | Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels |
| Q91810352 | The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD |
| Q60646598 | The role of meta-analyses and umbrella reviews in assessing the harms of psychotropic medications: beyond qualitative synthesis |
| Q64294159 | Uric Acid and Its Correlation with Various Metabolic Parameters: A Population-Based Study |
| Q97523467 | Uric Acid and Prevalence of Hypertension in a General Population of Japanese: ISSA-CKD Study |
| Q47833539 | Uric acid and diabetes risk among Chinese women with a history of gestational diabetes mellitus |
| Q89184416 | Uric acid and progression of chronic kidney disease |
Search more.